Phosphorylation
Showing 1 - 25 of 1,203
ALK Phosphorylation Trial in Harbin (crizotinib for rearrangement-negative, high phosphorylated ALK patients)
Completed
- ALK Phosphorylation
- crizotinib for rearrangement-negative, high phosphorylated ALK patients
-
Harbin, Heilongjiang, ChinaHarbin Medical University Cancer Hospital
Mar 19, 2023
Glioblastoma, IDH-wildtype Trial in France, Italy (Metformin, Radiation IMRT, Temozolomide)
Not yet recruiting
- Glioblastoma, IDH-wildtype
- Metformin
- +2 more
-
Suresnes, Hauts De Seine, France
- +5 more
Aug 2, 2022
Metabolism, Infection, and Immunity in Inborn Errors of
Recruiting
- Oxidative Phosphorylation Deficiencies
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Sperm Capacitation Trial in Sevilla (Analysis of capacitation-associated tyrosine phosphorylation in human sperm by flow
Recruiting
- Sperm Capacitation
- Analysis of capacitation-associated tyrosine phosphorylation in human sperm by flow cytometry
-
Sevilla, SpainIVI RMA Sevilla
Jul 5, 2021
Septic Shock, Platelet Signal Processing Defect, Inflammatory Response Trial in Bruxelles (Assessment of coagulopathy, Platelets
Active, not recruiting
- Septic Shock
- +5 more
- Assessment of coagulopathy, Platelets activation and Platelets-Neutrophils interplay
-
Bruxelles, BelgiumCliniques Universitaires St Luc
Apr 26, 2021
Kinase Inhibitors Based on Protein Phosphorylation Profiles in
Terminated
- Renal Cell Cancer
-
Amsterdam, Noord Holland, NetherlandsVU Medical Center
Nov 18, 2020
Type 2 Diabetes Trial in Los Angeles (Liraglutide)
Withdrawn
- Type 2 Diabetes
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Sep 26, 2019
Advanced Malignant Solid Tumor, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in
Completed
- Advanced Malignant Solid Neoplasm
- +24 more
- Oxidative Phosphorylation Inhibitor IACS-010759
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 23, 2020
Alzheimer's Disease, Mild Cognitive Impairment Trial in Irvine, Los Angeles (Nicotinamide, Placebo Comparator)
Completed
- Alzheimer's Disease
- Mild Cognitive Impairment
- Nicotinamide
- Placebo Comparator
-
Irvine, California
- +1 more
Dec 14, 2022
Heart Failure With Preserved Ejection Fraction Trial in Philadelphia (Empagliflozin + Potassium Chloride, Empagliflozin +
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Empagliflozin + Potassium Chloride
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Health System
May 25, 2022
Mature B Cell Tumors Trial in Tianjin (SHR1459)
Active, not recruiting
- Mature B Cell Neoplasms
-
Tianjin, Tianjin, ChinaBlood disease hospital of Chinese Academy of Medical Sciences
Nov 10, 2022
Systemic and White Adipose Tissue Inflammatory Profile in Lean
Completed
- Inflammation
- +3 more
- No intervention
-
Loughborough, United KingdomLoughborough University
May 15, 2022
Gestational Diabetes, Vascular Endothelial Function Trial in Iowa City (Acetylcholine, insulin aspart)
Recruiting
- Gestational Diabetes
- Vascular Endothelial Function
- Acetylcholine
- insulin aspart
-
Iowa City, IowaUniversity of Iowa
Jul 7, 2023
Type2 Diabetes, Insulin Resistance Trial in Odense (Acute exercise)
Completed
- Type2 Diabetes
- Insulin Resistance
- High intensity interval training
-
Odense, DenmarkDepartment of Endocrinology, Odense University Hospital
Aug 31, 2022
Alzheimer Trial in Saint Louis (Lemborexant 25 mg, Placebo)
Recruiting
- Alzheimer Disease
- Lemborexant 25 mg
- Placebo
-
Saint Louis, MissouriWashington University School of Medicine
Feb 16, 2023
Postpartum Hemorrhage Trial in Toronto (Oxytocin)
Recruiting
- Postpartum Hemorrhage
-
Toronto, Ontario, CanadaMount Sinai Hospital
Oct 24, 2022
HIV Infection Primary Trial in Badalona (Dasatinib 70 mg, Placebo)
Not yet recruiting
- HIV Infection Primary
- Dasatinib 70 mg
- Placebo
-
Badalona, Barcelona, SpainHospital Universitari Germans Trias i Pujol
Mar 9, 2023
Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)
Active, not recruiting
- Adult Solid Neoplasm
- Erlotinib Hydrochloride
- Irinotecan Hydrochloride
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 12, 2023
Exercise Response in Humans With Obesity
Not yet recruiting
- Obese
- Treadmill Test
- +6 more
-
Rochester, MinnesotaMayo Clinic in Rochester
May 4, 2023
Inflammation Trial in Kelowna (Moderate intensity continuous exercise, High intensity continuous exercise, High intensity
Recruiting
- Inflammation
- Moderate intensity continuous exercise
- +3 more
-
Kelowna, British Columbia, CanadaUBC Okanagan
Oct 6, 2022
Aging, Sarcopenia Trial in Derby (High intensity interval training (HIIT), Resistance based training (RET))
Recruiting
- Aging
- Sarcopenia
- High intensity interval training (HIIT)
- Resistance based training (RET)
-
Derby, Derbyshire, United KingdomGraduate Entry Medical School, University of Nottingham, Royal D
Jul 6, 2023
Abdominal Pain, Barrett Esophagus, Gastroesophageal Reflux Disease Trial in Philadelphia (Esophagogastroduodenoscopy,
Recruiting
- Barrett Esophagus
- Gastroesophageal Reflux Disease
- Biopsy
- +4 more
-
Philadelphia, Pennsylvania
- +1 more
Oct 27, 2022
Glioblastoma, Recurrent Glioblastoma Trial in Atlanta (Avutometinib, Biospecimen Collection, Defactinib)
Not yet recruiting
- Glioblastoma
- Recurrent Glioblastoma
- Avutometinib
- +2 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Mar 22, 2023